November 2023

Eccogene will receive initial upfront payment of $185 million. Eccogene is also eligible to receive up to $1.825 billion in future clinical, regulatory, and commercial milestones, as well as royalty payments. AstraZeneca will receive an exclusive license to develop and commercialize ECC5004 in all t

NEW YORK, Nov. 9, 2023 /PRNewswire/ — The enzymes market is estimated to grow by USD 2,745.12 million from 2021 to 2026. However, the growth momentum will be progressing at a CAGR of 5.36%  during the forecast period. The growing competition in the market is compelling vendors to adopt var

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: